FdaNdcDirectoryPulse / compare
BRYTLY vs BPHXVCM WART REMOVER Patches: FdaNdcDirectoryPulse comparison
BRYTLY (2026-10-16) and BPHXVCM WART REMOVER Patches (2026-09-30) are peer FdaNdcDirectoryPulse records.
Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA
Both records plus every comparable record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe
How does BRYTLY compare to BPHXVCM WART REMOVER Patches?
| Field | BRYTLY | BPHXVCM WART REMOVER Patches |
|---|---|---|
| Product | BRYTLY | BPHXVCM WART REMOVER Patches |
| Generic name | Apraclonidine Hydrochloride | Salicylic acid 40% WART REMOVER Patches |
| NDC | 0065-8596 | 87957-026 |
| Labeler | Alcon Laboratories, Inc. | Hubei Minxin Pharmaceutical Co., Ltd. |
| Product type | HUMAN OTC DRUG | HUMAN OTC DRUG |
| Approval pathway | NDA | OTC MONOGRAPH DRUG |
| Application number | NDA220341 | M028 |
| Dosage form | SOLUTION/ DROPS | PATCH |
| Route | OPHTHALMIC | TOPICAL |
| Active ingredients | APRACLONIDINE HYDROCHLORIDE 1.25 mg/mL | SALICYLIC ACID 40 g/1001 |
| Marketing start | 2026-10-16 | 2026-09-30 |
| Package configurations | 3 | 1 |
| Launch Signal Score | 45/100 | 15/100 |
| Peer rank and all 500 records (CSV) | 🔒 Click to unlock → | |
| Official source URLs for every peer record | 🔒 Click to unlock → | |
Official records: BRYTLY · BPHXVCM WART REMOVER Patches
Get new listings in your categories
FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.